Cargando…

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more

Detalles Bibliográficos
Autores principales:	Connors, Jean M, Ridker, Paul M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243566/ https://www.ncbi.nlm.nih.gov/pubmed/35779559 http://dx.doi.org/10.1016/S2352-3026(22)00205-8

Ejemplares similares

COVID-19: ACT trials for colchicine and antithrombotic therapies
por: Barco, Stefano, et al.
Publicado: (2022)

Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2
por: Carneiro, Jorge David Aivazoglou, et al.
Publicado: (2020)

Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Challenging tumor resistance with less toxic, more effective drug combinations: an example from neuroblastoma
por: Gambacurta, Alessandra, et al.
Publicado: (2018)

More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021)

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
por: Wang, Tao, et al.
Publicado: (2020)

Fluvoxamine for outpatients with COVID-19: where do we stand?
por: Berwanger, Otavio
Publicado: (2022)

Antithrombotic Prophylaxis in the Middle East
por: Arnaout, Samir, et al.
Publicado: (2011)

Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient?
por: Becker, Richard C.
Publicado: (2017)

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis
por: Takasaki, Kazuki, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care
por: Jones, Daniel, et al.
Publicado: (2020)

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients
por: Symonds, Erin L., et al.
Publicado: (2022)

Diabetes and covid-19: more than the sum of two morbidities
por: Pititto, Bianca de Almeida, et al.
Publicado: (2020)

Covid-19 vaccine apps should deliver more to patients
por: Dasgupta, Nabarun, et al.
Publicado: (2021)

RAS inhibition and COVID-19: more questions than answers?
por: Kerneis, Mathieu, et al.
Publicado: (2021)

More evidence for worse COVID-19 outcomes in people with HIV
por: Boffito, Marta, et al.
Publicado: (2021)

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
por: Kessler, Chiara, et al.
Publicado: (2020)

Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
por: Ciavarella, Alessandro, et al.
Publicado: (2020)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Stacking of antithrombotic drugs in cardiology: evidence-based customisation
por: Peters, R. J. G.
Publicado: (2022)

Cessation of antithrombotic therapy before surgery: weighing thrombosis and bleeding risks
por: Meesters, M. I., et al.
Publicado: (2014)

Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19
por: Li, Jing-Xin, et al.
Publicado: (2021)

COVID-19 and ECMO: a call for close cooperation and more investigation
por: Lorusso, Roberto, et al.
Publicado: (2021)

Counting stillbirths and COVID 19—there has never been a more urgent time
por: Homer, Caroline S E, et al.
Publicado: (2021)

The COVID-19 vaccines rush: participatory community engagement matters more than ever
por: Burgess, Rochelle Ann, et al.
Publicado: (2021)

Less Is More During COVID 19
por: Leeman, Jonathan E., et al.
Publicado: (2020)

Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022)

Covid-19 and the need for perinatal mental health professionals: now more than ever before
por: Hynan, Michael T.
Publicado: (2020)

How policymakers and other leaders can build a more sustainable post-COVID-19 ‘normal’
por: Bragge, Peter, et al.
Publicado: (2022)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2021)

Optimal Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: Is the “Less Is More” Concept Always Better?
por: Ko, Euihong, et al.
Publicado: (2021)

Rigorous and consistent evaluation of diagnostic tests in children: another unmet need
por: Caldwell, Christine S., et al.
Publicado: (2020)

Why diabetes outpatient clinics should not close during pandemic crises
por: Fadini, G. P., et al.
Publicado: (2021)

Covid-19 and the need for more history and philosophy of RNA
por: Guttinger, Stephan
Publicado: (2021)

Thrombosis and Hemophilia: Little More Evidence, Much More Guidance
por: Hermans, Cedric
Publicado: (2023)

Mentoring is more important than ever
por: Heemstra, Jennifer M., et al.
Publicado: (2022)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8qvfpb1dcplod01ipakjq316sp